---
figid: PMC7216198__ijms-21-02926-g008
figlink: pmc/articles/PMC7216198/figure/ijms-21-02926-f008/
number: F8
caption: Regulatory role of the IPs in immune surveillance in PB CD34+ Cells of PMF
  JAK2V617F mutated patients. The activation of JAK2 pathway, in a classical manner
  through the binding of IFNG to its receptor (IFNGR1/2) or through the JAK2V617F
  mutation, induces the expression of the immunoproteasome-specific subunits β1i (PSMB9),
  β2i (PSMB10), β5i (PSMB8), PA28 (PSME1), and PA28 (PSME2) (via STAT1 and IRF1) that
  result in the preferred assembly of the immunoproteasome over the regular proteasome.
  The resulting immuno-peptidome more effectively binds to MHC class I molecules (induced
  during the activation of JAK2), such that after processing in the endoplasmic reticulum
  (ER) (TAP1 and TAP2) and Golgi apparatus the individual peptides presented on the
  cell surface can be recognized by T-cell receptors on CD8+ cells, initiating an
  immune response (increased ARG1 expression is known to result in arginine deficiency,
  which leads to immunosuppression by impairing lymphocyte proliferation and activation).
pmcid: PMC7216198
papertitle: Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells
  from Primary Myelofibrosis Patients.
reftext: Michelino Di Rosa, et al. Int J Mol Sci. 2020 Apr;21(8):2926.
pmc_ranked_result_index: '36039'
pathway_score: 0.9767581
filename: ijms-21-02926-g008.jpg
figtitle: Regulatory role of the IPs in immune surveillance in PB CD34+ Cells of PMF
  JAK2V617F mutated patients
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7216198__ijms-21-02926-g008.html
  '@type': Dataset
  description: Regulatory role of the IPs in immune surveillance in PB CD34+ Cells
    of PMF JAK2V617F mutated patients. The activation of JAK2 pathway, in a classical
    manner through the binding of IFNG to its receptor (IFNGR1/2) or through the JAK2V617F
    mutation, induces the expression of the immunoproteasome-specific subunits β1i
    (PSMB9), β2i (PSMB10), β5i (PSMB8), PA28 (PSME1), and PA28 (PSME2) (via STAT1
    and IRF1) that result in the preferred assembly of the immunoproteasome over the
    regular proteasome. The resulting immuno-peptidome more effectively binds to MHC
    class I molecules (induced during the activation of JAK2), such that after processing
    in the endoplasmic reticulum (ER) (TAP1 and TAP2) and Golgi apparatus the individual
    peptides presented on the cell surface can be recognized by T-cell receptors on
    CD8+ cells, initiating an immune response (increased ARG1 expression is known
    to result in arginine deficiency, which leads to immunosuppression by impairing
    lymphocyte proliferation and activation).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD8A
  - CD8B
  - IFNG
  - TRA
  - TRB
  - TRD
  - TRG
  - PRB1
  - ARG1
  - HLA-A
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT1
  - PSME2
  - PSME1
  - ISYNA1
  - IRF1
  - TAP1
  - TAP2
  - B2M
  - PSMB8
  - PSMB9
  - GAST
  - IFNA1
  - CD34
  - L-arginine
  - TCR
  - PB
  - Cytotoxic
genes:
- word: CD8
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PMF
  symbol: PMF
  source: hgnc_alias_symbol
  hgnc_symbol: PRB1
  entrez: '5542'
- word: ARG1
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: HLA-A
  symbol: HLA-A
  source: hgnc_symbol
  hgnc_symbol: HLA-A
  entrez: '3105'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PSME1/2
  symbol: PSME2
  source: hgnc_symbol
  hgnc_symbol: PSME2
  entrez: '5721'
- word: PSME1/2
  symbol: PSME1
  source: hgnc_symbol
  hgnc_symbol: PSME1
  entrez: '5720'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: (IPs)
  symbol: IPS
  source: hgnc_alias_symbol
  hgnc_symbol: ISYNA1
  entrez: '51477'
- word: IRF1
  symbol: IRF1
  source: hgnc_symbol
  hgnc_symbol: IRF1
  entrez: '3659'
- word: IRF1
  symbol: IRF1
  source: hgnc_symbol
  hgnc_symbol: IRF1
  entrez: '3659'
- word: ARG1
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: TAP1
  symbol: TAP1
  source: hgnc_symbol
  hgnc_symbol: TAP1
  entrez: '6890'
- word: TAP2
  symbol: TAP2
  source: hgnc_symbol
  hgnc_symbol: TAP2
  entrez: '6891'
- word: B2M
  symbol: B2M
  source: hgnc_symbol
  hgnc_symbol: B2M
  entrez: '567'
- word: IRF1
  symbol: IRF1
  source: hgnc_symbol
  hgnc_symbol: IRF1
  entrez: '3659'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PSMB8
  symbol: PSMB8
  source: hgnc_symbol
  hgnc_symbol: PSMB8
  entrez: '5696'
- word: IRF1
  symbol: IRF1
  source: hgnc_symbol
  hgnc_symbol: IRF1
  entrez: '3659'
- word: PSMB9
  symbol: PSMB9
  source: hgnc_symbol
  hgnc_symbol: PSMB9
  entrez: '5698'
- word: TAP2
  symbol: TAP2
  source: hgnc_symbol
  hgnc_symbol: TAP2
  entrez: '6891'
- word: TAP1
  symbol: TAP1
  source: hgnc_symbol
  hgnc_symbol: TAP1
  entrez: '6890'
- word: ARG1
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: (GAS)
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: CD34+
  symbol: CD34
  source: hgnc_symbol
  hgnc_symbol: CD34
  entrez: '947'
chemicals:
- word: L-arginine
  source: ''
  identifier: ''
- word: TCR
  source: MESH
  identifier: D017260
- word: PB
  source: MESH
  identifier: D010634
diseases:
- word: Cytotoxic
  source: MESH
  identifier: D064420
figid_alias: PMC7216198__F8
redirect_from: /figures/PMC7216198__F8
figtype: Figure
---
